TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33368237

Group type: EXPERIMENTAL
Intervention: Structured delivery preparation education
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no structured delivery preparation education)
Number of subjects: 160
Study: 33270142

Group type: EXPERIMENTAL
Intervention: Cervical headgear treatment for 2 years
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 67
Study: 35966784

Group type: EXPERIMENTAL
Intervention: Sulforaphane (SFN)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 33144350

Group type: EXPERIMENTAL
Intervention: i-CONTENT tool
Number of subjects: 49
Study: 35048309

Group type: EXPERIMENTAL
Intervention: Health-promotion intervention
Number of subjects: 0
Study: 33246001

Group type: EXPERIMENTAL
Intervention: TMD group
Number of subjects: 33
Study: 32093635

Group type: EXPERIMENTAL
Intervention: High sensitivity for type 1 algorithm (ratio of type 1 to type 2 codes ≥ 4, or at least 1 insulin prescription within 90 days)
Number of subjects: 15297

Group type: EXPERIMENTAL
Intervention: High PPV for type 1 algorithm (ratio of type 1 to type 2 codes ≥ 4, and multiple daily injections with no other glucose‐lowering medication prescription)
Number of subjects: 15297

Group type: EXPERIMENTAL
Intervention: Optimized algorithm (ratio of type 1 to type 2 codes ≥ 4, and at least 1 insulin prescription within 90 days)
Number of subjects: 15297

Group type: EXPERIMENTAL
Intervention: All algorithms for T2D classification
Number of subjects: 15297
Study: 35684083

Group type: EXPERIMENTAL
Intervention: Time-Restricted Feeding (TRF)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual Feeding Pattern (UFP)
Number of subjects: 41
Study: 34523063

Group type: EXPERIMENTAL
Intervention: Viloxazine extended-release capsules (viloxazine ER; Qelbree™) 100-600 mg/day for 6-8 weeks
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1154
Study: 36282205

Group type: EXPERIMENTAL
Intervention: S.T.O.P. F2 contact lenses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: S.T.O.P. DT contact lenses
Number of subjects: 0

Group type: COMPARATOR
Intervention: MiSight contact lenses
Number of subjects: 0
Study: 34417215

Group type: EXPERIMENTAL
Intervention: Closed reduction and cast immobilisation (long arm cast for 6 weeks)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Flexible intramedullary nails (immobilised in a collar and cuff sling for 4 weeks)
Number of subjects: 78
Study: 35614368

Group type: EXPERIMENTAL
Intervention: PROSPER intervention
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 197
Study: 32211908

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) injection
Number of subjects: 18

Group type: COMPARATOR
Intervention: Laser photocoagulation
Number of subjects: 18
Study: 32289159

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 27395
Study: 32792252

Group type: EXPERIMENTAL
Intervention: Quetiapine XR at a dose of 300 mg once daily
Number of subjects: 505
Study: 35099359

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-i) with therapist guidance
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-i) without therapist guidance
Number of subjects: 133

Group type: COMPARATOR
Intervention: Waitlist control group receiving unguided treatment after a delay
Number of subjects: 133
Study: 33932626

Group type: EXPERIMENTAL
Intervention: Motivational Interview (MI)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study: 37877914

Group type: EXPERIMENTAL
Intervention: Sirolimus-Coated Balloon (SCB)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Paclitaxel-Coated Balloon (PCB)
Number of subjects: 121
Study: 33491436

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma separation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acute isovolumic hemodilution
Number of subjects: 80
Study: 34289212

Group type: EXPERIMENTAL
Intervention: ConquerFear-Group (CF-G)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Active Control (AC) - relaxation training
Number of subjects: 27
Study: 34201810

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 22
Study: 34467669

Group type: EXPERIMENTAL
Intervention: Nutrition counselling using a digital job aid
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Usual practice (comparison arm)
Number of subjects: 1500
Study: 33494844

Group type: EXPERIMENTAL
Intervention: Calcium intake (936 mg/day)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Magnesium intake (315 mg/day)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Phosphorus intake (1350 mg/day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Total calcium intake (1026 mg/day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Dietary magnesium intake (331 mg/day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Dietary phosphorus intake (1402 mg/day)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Calcium, magnesium, and phosphorus intakes
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Interactions between intakes of these minerals and total fat
Number of subjects: 150
Study: 32342519

Group type: EXPERIMENTAL
Intervention: miRNA-based prognostic signature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk signature-based nomogram model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: miR-1229-3p
Number of subjects: 0
Study: 34687053

Group type: EXPERIMENTAL
Intervention: Reciproc Blue (RCB) size 25, 0.08 taper
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: XP-endo Shaper (XPS) size 30, 0.01 taper
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: R-Motion (RM) size 30, 0.04 taper
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HyFlex CM (HFX) size 30, 0.04 taper
Number of subjects: 40
Study: 33295974

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib-bevacizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study: 35852825

Group type: COMPARATOR
Intervention: Autoclaving only (AU)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl) + AU
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Electrochemical treatment (EC) + AU
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NaOCl + EC + AU
Number of subjects: 80

Group type: COMPARATOR
Intervention: Positive control (contaminated without any treatment)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Negative controls (new unused HAs)
Number of subjects: 80
Study: 34310172

Group type: EXPERIMENTAL
Intervention: Acalabrutinib 100 mg twice daily
Number of subjects: 533

Group type: COMPARATOR
Intervention: Ibrutinib 420 mg once daily
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Number of subjects: 533

Group type: COMPARATOR
Intervention: Ibrutinib
Number of subjects: 533
Study: 35686579

Group type: COMPARATOR
Intervention: IBS normal threshold (IBS-NT) cluster
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: IBS increased threshold (IBS-IT) cluster
Number of subjects: 80
Study: 33770710

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS over DMPFC
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 33
Study: 35793183

Group type: EXPERIMENTAL
Intervention: Vertebral Body Tethering (VBT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Posterior Spinal Instrumentation (PI)
Number of subjects: 31
Study: 33479800

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) after 60 seconds
Number of subjects: 110

Group type: COMPARATOR
Intervention: Early cord clamping (ECC) within 30 seconds
Number of subjects: 110
Study: 32362226

Group type: EXPERIMENTAL
Intervention: Mobile personal health record application (mPHR)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 311
Study: 34382217

Group type: EXPERIMENTAL
Intervention: HPV self-testing
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Colposcopy
Number of subjects: 28
Study: 32659637

Group type: EXPERIMENTAL
Intervention: Workshop
Number of subjects: 1173

Group type: EXPERIMENTAL
Intervention: Apprenticeship
Number of subjects: 1173

Group type: EXPERIMENTAL
Intervention: Consult
Number of subjects: 1173

Group type: COMPARATOR
Intervention: Doing nothing
Number of subjects: 1173
Study: 35078555

Group type: EXPERIMENTAL
Intervention: SRT plus ESC
Number of subjects: 270

Group type: COMPARATOR
Intervention: ESC alone
Number of subjects: 270
Study: 34145486

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 12

Group type: COMPARATOR
Intervention: SIT
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HIIT and SIT
Number of subjects: 12
Study: 34083384

Group type: EXPERIMENTAL
Intervention: GPR84 and FFAR4 agonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33606782

Group type: EXPERIMENTAL
Intervention: Public health measures (masking, physical distancing, contact tracing app, willingness to take a COVID-19 vaccine)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Public health messaging
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 3000
Study: 36344876

Group type: EXPERIMENTAL
Intervention: Standard Behavioral Parent Training (Helping the Noncompliant Child, HNC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Technology-enhanced Behavioral Parent Training (TE-HNC)
Number of subjects: 101
Study: 33405082

Group type: EXPERIMENTAL
Intervention: EGCG150 (150 mg/kg EGCG)
Number of subjects: 768
Study: 36134437

Group type: EXPERIMENTAL
Intervention: Early-treated phenylketonuria (ETPKU) group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy individuals without PKU (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ETPKU group
Number of subjects: 40
Study: 33797306

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral skills training
Number of subjects: 86

Group type: COMPARATOR
Intervention: Waitlist period control
Number of subjects: 86
Study: 35135585

Group type: EXPERIMENTAL
Intervention: Virtual Arm Boot Camp (V-ABC) with feedback from a wearable device and 6 virtual sessions with a therapist
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Virtual Arm Boot Camp (V-ABC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (3-week delayed entry)
Number of subjects: 64
Study: 34340122

Group type: EXPERIMENTAL
Intervention: 0.05% ?-mannanase enzyme in CSL diet
Number of subjects: 256

Group type: COMPARATOR
Intervention: CSL diet without ?-mannanase enzyme
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: CSL with ?-mannanase enzyme
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: ?‐mannanase enzyme
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control (CS) diet
Number of subjects: 256
Study: 32160897

Group type: EXPERIMENTAL
Intervention: Counseling using the Skills Training Approach (STA)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 68
Study: 35582122

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1000
Study: 33939887

Group type: EXPERIMENTAL
Intervention: Curcumin and other polyphenol extracts (turmeric, red clover, flaxseed, resveratrol) at a dosage of 3 capsules/day (296.4 mg phenolics/capsule) for 5 ± 2 days before surgery
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no capsules)
Number of subjects: 26
Study: 34037693

Group type: EXPERIMENTAL
Intervention: Anterior Approach Hepatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Hepatectomy
Number of subjects: 0
Study: 35605174

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 1278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1278
Study: 33449603

Group type: EXPERIMENTAL
Intervention: Sit-to-stand desk
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Treadmill desk
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 32755213

Group type: EXPERIMENTAL
Intervention: CT urography (CTU)
Number of subjects: 419
Study: 34668323

Group type: EXPERIMENTAL
Intervention: Gratitude
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Kindness
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control
Number of subjects: 107
Study: 33761119

Group type: EXPERIMENTAL
Intervention: Fever prevention using the Arctic Sun System
Number of subjects: 1176

Group type: COMPARATOR
Intervention: Standard temperature management (usual care)
Number of subjects: 1176
Study: 32819312

Group type: EXPERIMENTAL
Intervention: Folate-oriented tertiary interventions including assessments of folate status and metabolism, folate intake guidance, and re-evaluation of folate status to ensure red blood cell folate level above 400 ng/ml before pregnancy.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine perinatal care (control arm).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Folate-oriented tertiary interventions.
Number of subjects: 0
Study: 35256203

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) on quadriceps muscles starting 1 day post LDLT for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-NMES (control) group
Number of subjects: 40
Study: 33743290

Group type: EXPERIMENTAL
Intervention: Individualized nutritional intervention
Number of subjects: 1874

Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 1874

Group type: EXPERIMENTAL
Intervention: NRS 2002 total score
Number of subjects: 1874
Study: 36181548

Group type: EXPERIMENTAL
Intervention: Mid-urethral sling (MUS) surgery
Number of subjects: 5200
Study: 34591584

Group type: EXPERIMENTAL
Intervention: Mentoring + Mindfulness
Number of subjects: 35

Group type: COMPARATOR
Intervention: Mentoring-as-usual
Number of subjects: 35
Study: 33625291

Group type: EXPERIMENTAL
Intervention: Active air purifiers
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo air purifiers
Number of subjects: 127
Study: 33571817

Group type: EXPERIMENTAL
Intervention: Highest quartile of urinary cadmium concentration (median = 0.20; 25th, 75th = 0.13, 0.32 μg cadmium/g creatinine)
Number of subjects: 19394

Group type: EXPERIMENTAL
Intervention: Per IQR increment in cadmium concentration
Number of subjects: 19394

Group type: EXPERIMENTAL
Intervention: Using creatinine or osmolality to account for differences in urine dilution
Number of subjects: 19394
Study: 32430769

Group type: EXPERIMENTAL
Intervention: Zero-profile device
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cage + plate
Number of subjects: 41
Study: 34435371

Group type: COMPARATOR
Intervention: MK-8507 200 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: MK-8507 800 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 18
Study: 33606754

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided forearm nerve block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Forearm intravenous regional anaesthesia (IVRA)
Number of subjects: 100
Study: 33044849

Group type: EXPERIMENTAL
Intervention: Concurrent aerobic-resistance (A-R) training
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Concurrent resistance-aerobic (R-A) training
Number of subjects: 51

Group type: COMPARATOR
Intervention: Concurrent training (CT) (both A-R and R-A)
Number of subjects: 51
Study: 34413391

Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercise intervention for 16 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 49
Study: 32090730

Group type: EXPERIMENTAL
Intervention: Vitamin D (100,000 IU per month for 24 months)
Number of subjects: 1615

Group type: COMPARATOR
Intervention: No treatment (open practices)
Number of subjects: 1615

Group type: COMPARATOR
Intervention: Placebo (double-blind practices)
Number of subjects: 1615

Group type: COMPARATOR
Intervention: Control (no treatment or placebo)
Number of subjects: 1615
Study: 35190446

Group type: EXPERIMENTAL
Intervention: Probucol (Lorelco)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 34940862

Group type: EXPERIMENTAL
Intervention: Protocolized sedation (intervention)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 960
Study: 33401019

Group type: EXPERIMENTAL
Intervention: Lipid-based nanoemulsion drops
Number of subjects: 99

Group type: COMPARATOR
Intervention: Non-lipid-based aqueous drops
Number of subjects: 99
Study: 34480522

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 33785589

Group type: EXPERIMENTAL
Intervention: Access to a pro bono lawyer
Number of subjects: 311

Group type: COMPARATOR
Intervention: Minimal help (control group)
Number of subjects: 311
Study: 33547808

Group type: EXPERIMENTAL
Intervention: L‐PRF+IBB
Number of subjects: 62

Group type: COMPARATOR
Intervention: CM+IBB
Number of subjects: 62
Study: 32265255

Group type: EXPERIMENTAL
Intervention: Insulin detemir (IDet) plus short acting insulin Novolin‐R before three meals (RRR‐IDet plan)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Neutral protamine Hagedorn (NPH) plus Novolin‐R before three meals (RRR‐NPH plan)
Number of subjects: 240
Study: 35637412

Group type: EXPERIMENTAL
Intervention: FOLFIRI plus cetuximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFIRI plus bevacizumab
Number of subjects: 0
Study: 33340081

Group type: EXPERIMENTAL
Intervention: PBMT (Photobiomodulation therapy)
Number of subjects: 44
Study: 33595486

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg/kg body weight) as an additive in peribulbar block
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 104
Study: 32553818

Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CMR/CT-derived sRV ejection fraction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of GLS and ejection fraction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mechanical dispersion (MD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Postsystolic shortening (PSS)
Number of subjects: 60
Study: 35881122

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept
Number of subjects: 118

Group type: COMPARATOR
Intervention: Laser photocoagulation
Number of subjects: 118
Study: 34293223

Group type: EXPERIMENTAL
Intervention: Temporally intensified exposure (PeEx-I)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Standard nonintensified exposure (PeEx-S)
Number of subjects: 726
Study: 32272516

Group type: EXPERIMENTAL
Intervention: HP/TAZ lotion (halobetasol propionate 0.01%/tazarotene 0.045%)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 219
Study: 35268098

Group type: EXPERIMENTAL
Intervention: Dextrin DP 3
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dextrin DP 60
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dextran DP 60
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-fully caloric Resistant Dextrin
Number of subjects: 10
Study: 32677156

Group type: EXPERIMENTAL
Intervention: Autologous umbilical cord blood (UCB) stem‐cell therapy
Number of subjects: 8
Study: 36455512

Group type: EXPERIMENTAL
Intervention: Values Affirmation Intervention + Fitspiration
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control Intervention + Fitspiration
Number of subjects: 238

Group type: COMPARATOR
Intervention: Travel (control - viewed travel images only)
Number of subjects: 238
Study: 34185582

Group type: EXPERIMENTAL
Intervention: FDM-informed manual therapy
Number of subjects: 33
Study: 33196667

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis initiation
Number of subjects: 151
Study: 35764923

Group type: EXPERIMENTAL
Intervention: GI_with (tool with integrated key questions)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: GI_without (tool without integrated key questions)
Number of subjects: 126

Group type: COMPARATOR
Intervention: GC (control group, routine care)
Number of subjects: 126
Study: 32157099

Group type: EXPERIMENTAL
Intervention: Physical exercise immediately before cognitive training
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Physical exercise immediately after cognitive training
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Physical exercise only
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cognitive training only
Number of subjects: 97
Study: 33438855

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33919819

Group type: EXPERIMENTAL
Intervention: Alcohol-related harm prevention program (3 sessions)
Number of subjects: 45
Study: 32472768

Group type: EXPERIMENTAL
Intervention: Universal 'test and treat' (UTT) with annual population testing and universal ART
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline population testing with ART by country standard
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Universal 'test and treat' (UTT)
Number of subjects: 0
Study: 34155501

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with capecitabine (1,000 mg/m2 b.i.d for 14 days) and intravenous cisplatin (75 mg/m2 at day 1, every 3 weeks)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 136
Study: 33661958

Group type: EXPERIMENTAL
Intervention: Whole-body exercise (hybrid functional electrical stimulation rowing) performed 2-3 times per week for 30-60 minutes with a target heart rate of >75% of maximum.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Arms only exercise (upper body rowing exercise) performed with the same prescription as whole-body exercise.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Waitlist control (no explicit training regimen).
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Post-hoc analysis for individuals with paraplegia.
Number of subjects: 61